BioSpace News Archive

Media are invited to send cameras to shoot b-roll of the repatriation facilities set up for Canadians returning from Wuhan, China, due to the novel coronavirus.

SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest success story on identifying new cost reduction opportunities and reducing procurement spend by 30% for a company in the UK pharmaceutical market.

The protein tau has long been implicated in Alzheimer’s and a host of other debilitating brain diseases. But scientists have struggled to understand exactly how tau converts from its normal, functional form into a misfolded, harmful one.

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of high-grade cannabis extracted ingredients for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, is pleased to announce the appointment of Michael Kinley CPA,CA to the position of Chief Financial Officer.

Feb. 6, 2020 18:00 UTC Hines to lead company’s expansion into clinical grade product lines FOLSOM, Calif.--( BUSINESS WIRE )-- StemExpress announced that Dr. Victoria Hines has been appointed Vice President of Clinical and will direct the company as they expand their offerings to include clinical grade products. Hines will lead global clinical operations, strategy and execution for StemExpress. The increasing demand for cell and gene therapies to treat various diseases

The Global Virus Network (GVN), representing 53 Centers of Excellence and 9 Affiliates in 32 countries comprising foremost experts in every class of virus causing disease in humans and some animals, is holding regular strategic discussions with its members regarding the growing novel coronavirus, known as 2019-nCoV, which originated in Wuhan, China this past December

Children’s Minnesota announced that Dave Lundal has been named chief information officer and vice president of information technology services.

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers, today announced it will hold an Investor Day Thursday, February 20, 2020.

Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively “HDF”), the beneficial owners of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), today announced that it has filed a complaint in the U.S. District Court for the Southern District of New York asserting direct claims against Enzo and asserting both direct and derivative claims against members of its Board of Directors (the “Board”) (Case 1:20-cv-01021).

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced that it has received clearance from the U.S. Food & Drug Administration to market the Steerable PLATEAU Ti System.